HASBRO, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HASBRO, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $5.37B | Feb 25, 2026 |
| FY2025 | Dec 29, 2024 | $4.75B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $5.71B | Feb 25, 2026 |
| FY2024 | Dec 25, 2022 | $6.67B | Feb 27, 2025 |
| FY2023 | Dec 26, 2021 | $6.42B | Feb 28, 2024 |
| FY2020 | Dec 27, 2020 | $1.72B | Feb 24, 2021 |
| FY2020 | Sep 27, 2020 | $1.78B | Feb 24, 2021 |
| FY2020 | Jun 28, 2020 | $860.28M | Feb 24, 2021 |
| FY2020 | Mar 29, 2020 | $1.11B | Feb 24, 2021 |
| FY2020 | Dec 29, 2019 | $1.43B | Feb 24, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $4.70B | Feb 25, 2026 |
| FY2025 | Dec 29, 2024 | $4.14B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $5.00B | Feb 25, 2026 |
| FY2024 | Dec 25, 2022 | $5.86B | Feb 27, 2025 |
| FY2023 | Dec 26, 2021 | $6.42B | Feb 28, 2024 |
| FY2022 | Dec 27, 2020 | $5.47B | Feb 22, 2023 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.60B | Feb 26, 2018 |
| FY2017 | Oct 1, 2017 | $1.79B | Feb 26, 2018 |
| FY2017 | Jul 2, 2017 | $972.51M | Feb 26, 2018 |
| FY2017 | Apr 2, 2017 | $849.66M | Feb 26, 2018 |
| FY2016 | Dec 25, 2016 | $1.63B | Feb 22, 2017 |
| FY2016 | Sep 25, 2016 | $1.68B | Feb 22, 2017 |
| FY2016 | Jun 26, 2016 | $878.95M | Feb 22, 2017 |
| FY2016 | Mar 27, 2016 | $831.18M | Feb 22, 2017 |
| FY2015 | Dec 27, 2015 | $1.47B | Feb 24, 2016 |
| FY2015 | Sep 27, 2015 | $1.47B | Feb 24, 2016 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | ($322.40M) | Feb 25, 2026 |
| FY2025 | Dec 29, 2024 | $385.60M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | ($1.49B) | Feb 25, 2026 |
| FY2024 | Dec 25, 2022 | $203.50M | Feb 27, 2025 |
| FY2023 | Dec 26, 2021 | $428.70M | Feb 28, 2024 |
| FY2020 | Dec 27, 2020 | $105.17M | Feb 24, 2021 |
| FY2020 | Sep 27, 2020 | $220.90M | Feb 24, 2021 |
| FY2020 | Jun 28, 2020 | ($33.92M) | Feb 24, 2021 |
| FY2020 | Mar 29, 2020 | ($69.64M) | Feb 24, 2021 |
| FY2020 | Dec 29, 2019 | $267.35M | Feb 24, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $11.10M | Feb 25, 2026 |
| FY2025 | Dec 29, 2024 | $690.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | ($1.54B) | Feb 25, 2026 |
| FY2024 | Dec 25, 2022 | $407.70M | Feb 27, 2025 |
| FY2023 | Dec 26, 2021 | $763.30M | Feb 28, 2024 |
| FY2020 | Dec 27, 2020 | $186.36M | Feb 24, 2021 |
| FY2020 | Sep 27, 2020 | $336.56M | Feb 24, 2021 |
| FY2020 | Jun 28, 2020 | $2.18M | Feb 24, 2021 |
| FY2020 | Mar 29, 2020 | ($23.28M) | Feb 24, 2021 |
| FY2020 | Dec 29, 2019 | $190.38M | Feb 24, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $385.60M | Feb 25, 2026 |
| FY2025 | Dec 29, 2024 | $294.10M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $306.90M | Feb 25, 2026 |
| FY2024 | Dec 25, 2022 | $307.90M | Feb 27, 2025 |
| FY2023 | Dec 26, 2021 | $315.70M | Feb 28, 2024 |
| FY2022 | Dec 27, 2020 | $259.50M | Feb 22, 2023 |
| FY2021 | Dec 29, 2019 | $262.20M | Feb 23, 2022 |
| FY2020 | Dec 30, 2018 | $246.17M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $269.02M | Feb 27, 2020 |
| FY2018 | Dec 25, 2016 | $266.38M | Feb 26, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $1.17B | Feb 25, 2026 |
| FY2025 | Dec 29, 2024 | $1.21B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $1.48B | Feb 25, 2026 |
| FY2024 | Dec 25, 2022 | $1.67B | Feb 27, 2025 |
| FY2023 | Dec 26, 2021 | $1.43B | Feb 28, 2024 |
| FY2022 | Dec 27, 2020 | $1.25B | Feb 22, 2023 |
| FY2021 | Dec 29, 2019 | $1.04B | Feb 23, 2022 |
| FY2020 | Dec 30, 2018 | $1.29B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $1.12B | Feb 27, 2020 |
| FY2018 | Dec 25, 2016 | $1.11B | Feb 26, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $893.20M | Feb 25, 2026 |
| FY2025 | Dec 29, 2024 | $847.40M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $725.60M | Feb 25, 2026 |
| FY2024 | Dec 25, 2022 | $372.90M | Feb 27, 2025 |
| FY2023 | Dec 26, 2021 | $817.90M | Feb 28, 2024 |
| FY2022 | Dec 27, 2020 | $976.30M | Feb 22, 2023 |
| FY2021 | Dec 29, 2019 | $653.10M | Feb 23, 2022 |
| FY2020 | Dec 30, 2018 | $646.00M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $724.38M | Feb 27, 2020 |
| FY2018 | Dec 25, 2016 | $817.31M | Feb 26, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $63.30M | Feb 25, 2026 |
| FY2025 | Dec 29, 2024 | $87.20M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $135.50M | Feb 25, 2026 |
| FY2024 | Dec 25, 2022 | $128.20M | Feb 27, 2025 |
| FY2023 | Dec 26, 2021 | $132.70M | Feb 28, 2024 |
| FY2022 | Dec 27, 2020 | $125.80M | Feb 22, 2023 |
| FY2021 | Dec 29, 2019 | $133.60M | Feb 23, 2022 |
| FY2020 | Dec 30, 2018 | $140.43M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $134.88M | Feb 27, 2020 |
| FY2018 | Dec 25, 2016 | $154.90M | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $5.55B | Feb 25, 2026 |
| FY2025 | Dec 29, 2024 | $6.34B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $6.54B | Feb 27, 2025 |
| FY2023 | Dec 25, 2022 | $9.30B | Feb 28, 2024 |
| FY2023 | Dec 26, 2021 | $10.04B | Feb 28, 2024 |
| FY2022 | Dec 27, 2020 | $10.82B | Feb 22, 2023 |
| FY2021 | Dec 29, 2019 | $8.86B | Feb 23, 2022 |
| FY2020 | Dec 30, 2018 | $5.26B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $5.29B | Feb 27, 2020 |
| FY2018 | Dec 25, 2016 | $5.09B | Feb 26, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $4.99B | Feb 25, 2026 |
| FY2025 | Dec 29, 2024 | $5.16B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $5.45B | Feb 27, 2025 |
| FY2023 | Dec 25, 2022 | $6.43B | Feb 28, 2024 |
| FY2022 | Dec 26, 2021 | $6.95B | Feb 22, 2023 |
| FY2021 | Dec 27, 2020 | $7.86B | Feb 23, 2022 |
| FY2020 | Dec 29, 2019 | $5.86B | Feb 24, 2021 |
| FY2019 | Dec 30, 2018 | $3.51B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $3.46B | Feb 26, 2019 |
| FY2017 | Dec 25, 2016 | $3.21B | Feb 26, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 29, 2019 | $3.00B | Feb 27, 2020 |
| FY2019 | Dec 30, 2018 | $1.75B | Feb 27, 2020 |
| FY2017 | Dec 31, 2017 | $1.83B | Feb 26, 2018 |
| FY2016 | Dec 25, 2016 | $1.86B | Feb 22, 2017 |
| FY2015 | Dec 27, 2015 | $1.66B | Feb 24, 2016 |
| FY2014 | Dec 28, 2014 | $1.47B | Feb 26, 2015 |
| FY2013 | Dec 29, 2013 | $1.68B | Feb 26, 2014 |
| FY2012 | Dec 30, 2012 | $1.51B | Feb 27, 2013 |
| FY2011 | Dec 25, 2011 | $1.42B | Feb 22, 2012 |
| FY2010 | Dec 26, 2010 | $1.62B | Feb 23, 2011 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $1.26B | Feb 25, 2026 |
| FY2025 | Dec 29, 2024 | $2.28B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $2.28B | Feb 25, 2026 |
| FY2024 | Dec 25, 2022 | $3.47B | Feb 27, 2025 |
| FY2023 | Dec 26, 2021 | $3.42B | Feb 28, 2024 |
| FY2022 | Dec 27, 2020 | $3.69B | Feb 22, 2023 |
| FY2021 | Dec 29, 2019 | $494.60M | Feb 23, 2022 |
| FY2020 | Dec 30, 2018 | $485.88M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $573.06M | Feb 27, 2020 |
| FY2018 | Dec 25, 2016 | $570.56M | Feb 26, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $1.55B | Feb 25, 2026 |
| FY2025 | Dec 29, 2024 | $2.27B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $2.19B | Feb 27, 2025 |
| FY2023 | Dec 25, 2022 | $4.07B | Feb 28, 2024 |
| FY2022 | Dec 26, 2021 | $4.26B | Feb 22, 2023 |
| FY2021 | Dec 27, 2020 | $4.20B | Feb 23, 2022 |
| FY2020 | Dec 29, 2019 | $4.35B | Feb 24, 2021 |
| FY2019 | Dec 30, 2018 | $4.18B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $4.26B | Feb 26, 2019 |
| FY2017 | Dec 25, 2016 | $4.15B | Feb 26, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 29, 2019 | $4.58B | Feb 27, 2020 |
| FY2019 | Dec 30, 2018 | $1.18B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.58B | Feb 26, 2019 |
| FY2018 | Dec 25, 2016 | $1.28B | Feb 26, 2019 |
| FY2018 | Dec 27, 2015 | $976.75M | Feb 26, 2019 |
| FY2017 | Dec 28, 2014 | $893.17M | Feb 26, 2018 |
| FY2016 | Dec 29, 2013 | $682.45M | Feb 22, 2017 |
| FY2015 | Dec 30, 2012 | $849.70M | Feb 24, 2016 |
| FY2014 | Dec 25, 2011 | $641.69M | Feb 26, 2015 |
| FY2013 | Dec 26, 2010 | $727.80M | Feb 26, 2014 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 27, 2020 | $4.66B | Feb 24, 2021 |
| FY2020 | Dec 29, 2019 | $4.05B | Feb 24, 2021 |
| FY2019 | Dec 30, 2018 | $1.70B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.69B | Feb 26, 2019 |
| FY2017 | Dec 25, 2016 | $1.20B | Feb 26, 2018 |
| FY2016 | Dec 27, 2015 | $1.55B | Feb 22, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | (2) | Feb 25, 2026 |
| FY2025 | Dec 29, 2024 | 2 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | (10) | Feb 25, 2026 |
| FY2024 | Dec 25, 2022 | 1 | Feb 27, 2025 |
| FY2023 | Dec 26, 2021 | 3 | Feb 28, 2024 |
| FY2020 | Dec 27, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Sep 27, 2020 | 1 | Feb 24, 2021 |
| FY2020 | Jun 28, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Mar 29, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Dec 29, 2019 | 2 | Feb 24, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | (2) | Feb 25, 2026 |
| FY2025 | Dec 29, 2024 | 2 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | (10) | Feb 25, 2026 |
| FY2024 | Dec 25, 2022 | 1 | Feb 27, 2025 |
| FY2023 | Dec 26, 2021 | 3 | Feb 28, 2024 |
| FY2020 | Dec 27, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Sep 27, 2020 | 1 | Feb 24, 2021 |
| FY2020 | Jun 28, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Mar 29, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Dec 29, 2019 | 2 | Feb 24, 2021 |